Kai Zhou

2.1k total citations
74 papers, 1.2k citations indexed

About

Kai Zhou is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Kai Zhou has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Cancer Research and 13 papers in Surgery. Recurrent topics in Kai Zhou's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Kai Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Kai Zhou collaborates with scholars based in China, Ethiopia and United States. Kai Zhou's co-authors include Di Yu, Hesuyuan Huang, Xiaodong Zang, Xuming Mo, Zhi Fu, Long Wang, Xiu‐Wu Bian, Yu Shi, Yi‐Fang Ping and Qiang Wang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Kai Zhou

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Zhou China 20 590 378 263 141 133 74 1.2k
Haoran Li China 14 491 0.8× 345 0.9× 336 1.3× 169 1.2× 187 1.4× 81 1.1k
F. Javier Carmona Spain 18 1.1k 1.9× 478 1.3× 262 1.0× 168 1.2× 151 1.1× 25 1.6k
Ewa Brzeziańska‐Lasota Poland 22 664 1.1× 307 0.8× 273 1.0× 106 0.8× 250 1.9× 113 1.5k
Krzysztof Goryca Poland 19 762 1.3× 326 0.9× 283 1.1× 142 1.0× 217 1.6× 69 1.3k
Xiang Gao China 19 498 0.8× 240 0.6× 218 0.8× 137 1.0× 190 1.4× 71 1.1k
Eleonora Petrucci Italy 22 856 1.5× 387 1.0× 358 1.4× 137 1.0× 205 1.5× 35 1.6k
Lara J. Monteiro Chile 19 1.3k 2.1× 449 1.2× 315 1.2× 100 0.7× 105 0.8× 36 1.8k
Ruixia Guo China 20 970 1.6× 673 1.8× 287 1.1× 106 0.8× 187 1.4× 90 1.6k
Shujun Lin China 16 822 1.4× 179 0.5× 354 1.3× 80 0.6× 206 1.5× 49 1.4k
Maria Grazia Cerrito Italy 19 526 0.9× 137 0.4× 251 1.0× 127 0.9× 116 0.9× 53 1.1k

Countries citing papers authored by Kai Zhou

Since Specialization
Citations

This map shows the geographic impact of Kai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Zhou more than expected).

Fields of papers citing papers by Kai Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Zhou. The network helps show where Kai Zhou may publish in the future.

Co-authorship network of co-authors of Kai Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Zhou. A scholar is included among the top collaborators of Kai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Zhou. Kai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Han, Shuzhen Cheng, Kai Zhou, et al.. (2025). Carboxymethyl-β-cyclodextrin grafted chitosan embedded oyster (Crassostrea gigas) ferritin can alleviate lead-induced liver injury by oral administration. Food Research International. 212. 116417–116417.
2.
Xue, Jingnan, Longhao Zhang, Kai Zhang, et al.. (2025). Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment. Frontiers in Immunology. 16. 1697056–1697056.
3.
Xue, Jingnan, Longhao Zhang, Kai Zhang, Kai Zhou, & Haitao Zhao. (2025). Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies. Frontiers in Immunology. 16. 1651769–1651769. 1 indexed citations
4.
Feng, Xinxin, Kaiyu Huang, Lei Chen, & Kai Zhou. (2023). Clinical efficacy of the shallow puncture and more-twirling acupuncture method in migraine treatment and its effects on serum 5-HT and β-EP levels. Technology and Health Care. 31(S1). 533–540. 8 indexed citations
5.
Wang, Lihong, Ye Yuan, Mingjun Zhong, et al.. (2023). KPT330 promotes the sensitivity of glioblastoma to olaparib by retaining SQSTM1 in the nucleus and disrupting lysosomal function. Autophagy. 20(2). 295–310. 5 indexed citations
6.
Xue, Zhiqiang, et al.. (2022). Risk factors of hospitalization costs and length of stay for tibial plateau fractures. European Journal of Trauma and Emergency Surgery. 48(4). 3177–3183.
7.
Yao, Ye, Huijun Liu, Xizi Du, et al.. (2022). Integrins are double-edged swords in pulmonary infectious diseases. Biomedicine & Pharmacotherapy. 153. 113300–113300. 5 indexed citations
8.
Zhou, Kai, et al.. (2022). Homo sapiens circular RNA 0003602 (Hsa_circ_0003602) accelerates the tumorigenicity of acute myeloid leukemia by modulating miR-502-5p/IGF1R axis. Molecular and Cellular Biochemistry. 477(2). 635–644. 11 indexed citations
9.
Chen, Jiahui, Kai Zhou, Anqiang Wang, et al.. (2021). Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer. Annals of Surgical Oncology. 28(8). 4413–4422. 11 indexed citations
10.
Wang, Xu, et al.. (2021). Chinese Parent Intention to Vaccinate Children With Special Diseases Against COVID-19. Frontiers in Public Health. 9. 725980–725980. 7 indexed citations
11.
Zhao, Jing, Kai Zhou, Liang Ma, & Huanyu Zhang. (2020). MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo. Bioengineered. 11(1). 219–228. 27 indexed citations
12.
Zhou, Kai, Anqiang Wang, Sheng Ao, et al.. (2020). The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer. 20(1). 671–671. 19 indexed citations
13.
Gao, Yixing, Erlong Zhang, Bao Liu, et al.. (2019). Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma. Journal of Cellular and Molecular Medicine. 23(9). 6228–6237. 15 indexed citations
14.
Xu, Mei, et al.. (2018). Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1. Molecular Carcinogenesis. 58(4). 577–587. 45 indexed citations
15.
Zhou, Kai, et al.. (2018). Clinical characteristics of Kawasaki disease shock syndrome in children and its related factors. Zhonghua shiyong erke linchuang zazhi. 33(9). 673–678. 2 indexed citations
16.
Zhou, Kai, et al.. (2016). MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Tumor Biology. 37(10). 13469–13477. 24 indexed citations
17.
Xu, Lin, Zhu Wang, Shanyang He, et al.. (2016). Bax-interacting factor-1 inhibits cell proliferation and promotes apoptosis in prostate cancer cells. Oncology Reports. 36(6). 3513–3521. 9 indexed citations
18.
Shi, Yu, Cong Chen, Shizhu Yu, et al.. (2015). miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma. Clinical Cancer Research. 21(17). 4004–4013. 49 indexed citations
20.
Yuan, Jiandong, et al.. (2014). The expression and function of miRNA-451 in osteosarcoma. Medical Oncology. 32(1). 324–324. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026